- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07489105
Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function (Forge AHEAD)
March 21, 2026 updated by: Chin-Yen Lin, Auburn University
Engaging Stakeholders and Patients to Evaluate the Feasibility of Yoga to Improve Cognitive Function in Rural Heart Failure Patients in the Deep South
The investigators will conduct a two-phase pilot study to test the feasibility and acceptability of a 12-week Chair Yoga intervention for 20 heart-failure patients.
Using a patient-centered approach, investigators will involve stakeholders in designing the protocol, gather patient feedback, and refine the protocol accordingly.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The aims of this study include:
Phase 1: Engaging stakeholders and patients to develop the initial study protocol.
- Engage stakeholders and patients to develop the initial study protocol.
- Recruit the first 10 patients to complete a 12-week online yoga intervention and collect data before and after the yoga intervention.
- Evaluate the feasibility of yoga intervention and revise the initial study protocol with stakeholders based on the data collected from the patients.
Phase 2: Pilot the revised protocol and finalize plans.
- Implement the revised study protocol for the next 10 patients, deliver a 12-week online yoga intervention, and collect data before and after the yoga intervention.
- Evaluate the pilot results on the feasibility of yoga intervention to enhance patient-centered outcomes and cognitive function based on the data collected from the patients.
- Finalize the study protocol with stakeholders and disseminate findings with communities.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chin-Yen Lin, PhD, RN
- Phone Number: 334-844-5619
- Email: czl0194@auburn.edu
Study Locations
-
-
Alabama
-
Auburn, Alabama, United States, 36849
- Recruiting
- Auburn University
-
Contact:
- Chin-Yen Lin
- Phone Number: 334-844-5619
- Email: czl0194@auburn.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Heart failure diagnosis
- Aged 55 years or older
Exclusion Criteria:
- Traumatic brain injury, co-existing neurological and psychiatric disorders
- Implanted defibrillator or metal objects, left ventricular assist device placement, or cardiac transplant
- Substance abuse
- Unable to perform yoga due to physical limitations or severity of illness
- Currently engaged in a yoga program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Chair yoga intervention
|
Chair yoga intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceptions and experiences of yoga practice measured by the Essential Properties of Yoga Questionnaire.
Time Frame: After completion of 12-week intervention.
|
Includes 62 items.
Rated on Likert scales from 0 (not at all) to 4 (a very large amount).
Score range converted to 0 to 100%, with higher scores indicating a stronger presence/intensity of the specific yoga property.
|
After completion of 12-week intervention.
|
|
Cognitive function measured by the Montreal Cognitive Assessment.
Time Frame: Baseline
|
Score range 0 to 30.
Score ≥26: generally normal (context-dependent); 18-25: mild impairment range; <18: more likely moderate-severe impairment.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related quality of life measured by the Minnesota Living with Heart Failure Questionnaire.
Time Frame: Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention.
|
Response scale: 0 (no impact) to 5 (very much).
Score ranges from 0 to 105, with higher scores indicating worse quality of life.
|
Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention.
|
|
Social factors of health measured by the Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences.
Time Frame: Baseline
|
For each PRAPARE item, mark responses indicating unmet social need as "1" (risk) and acceptable/no-need responses as "0."
Scores are calculated by summing each item; higher scores indicate more social needs.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 24, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
March 17, 2026
First Submitted That Met QC Criteria
March 19, 2026
First Posted (Actual)
March 23, 2026
Study Record Updates
Last Update Posted (Actual)
March 25, 2026
Last Update Submitted That Met QC Criteria
March 21, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AU-25-001
- 5P50MD017338-04 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Yoga group
-
University of California, San FranciscoMount Zion Health Fund; Pritzker Family Foundation; Mental Insight FoundationCompletedDepression, UnipolarUnited States
-
University of OsloCompletedMental Health | Depression, Anxiety | Sleep Problem | Public Health | University StudentsNorway
-
Colorado State UniversityCompleted
-
Jenilee SneedWithdrawnPsychological Distress | Mindfulness
-
Region Örebro CountyCompletedDepression | Stress | Anxiety
-
Robert SaperThe Cleveland ClinicCompletedBack Pain | Chronic PainUnited States
-
Celal Bayar UniversityCompletedHealthy ParticipantsTurkey
-
Dokuz Eylul UniversitySuspendedAnkylosing Spondylitis | YogaTurkey
-
Centre for Addiction and Mental HealthCompleted